India’s central drug regulatory agency has neither disclosed whether it investigated an alleged counterfeit anti-rabies vaccine nor named the companies or products involved in 694 other quality-related enforcement actions against drug makers. Rabies is a viral infection that attacks the central nervous system, particularly the brain, and is almost always fatal if not prevented. The vaccine is used to prevent infection after exposure to the virus, not to treat the disease once symptoms appear. “The silence on something as critical as a rabies vaccine is shocking,” an industry executive familiar with drug regulatory affairs told The Telegraph. But an official who requested anonymity said the CDSCO sent letters to all state drug regulators seeking follow-up action.

Source: The Telegraph January 01, 2026 09:21 UTC